Duolin Rotacaps
Generic: Levosalbutamol/Ipratropiumby Cipla Limited

Select pack size
Similar medicines
View allAbout Duolin Rotacaps
Duolin Rotacaps are dry powder capsules made in India by Cipla for use with a Rotahaler inhaler device. Each capsule (Rotacap) contains levosalbutamol 100 mcg, a short-acting beta2 agonist bronchodilator, and ipratropium 40 mcg, a short-acting antimuscarinic bronchodilator. Indian pharmacy listings describe them for chronic obstructive pulmonary disease (COPD). Levosalbutamol (levalbuterol in the US) is the R-isomer of salbutamol (albuterol). Our pack selector counts containers: the carton and container in our product photo each say 30 capsules. We sell 1, 2 and 3 containers, from $0.32 a capsule in the 3 pack, before shipping.
Five points first. No inhaler, capsule or nebuliser that combines levosalbutamol with ipratropium is approved in the US or Canada, we found none licensed in the UK, and we could not find one registered in Australia; the licensed combination in those countries uses ordinary (racemic) salbutamol, for example Combivent Respimat in the US and Canada. We have not seen Cipla's prescribing information for Duolin Rotacaps, and the Indian listings give no dose schedule, so your doctor needs to set how often you use them. They contain no inhaled steroid, so they are not a treatment for asthma on their own. The capsules are for inhalation only: never swallow one. And they are sensitive to moisture, so how you store and handle the container matters more than it does for a pressurised inhaler. Clinical figures on this page come from the US labels for Combivent Respimat, Atrovent HFA and Xopenex HFA and the UK label for the Atrovent inhaler, listed at the end.
Duolin Rotacaps at a glance
| Active ingredients | Levosalbutamol 100 mcg and ipratropium 40 mcg per capsule (PharmEasy, Apollo and Tata 1mg listings). The container in our photo reads "Levosalbutamol Sulphate and Ipratropium Bromide Rotacaps"; whether 100 mcg counts levosalbutamol or its sulphate salt is not confirmed |
| Brand and maker | Duolin Rotacaps, by Cipla Limited, India (PharmEasy names the Malpur, Solan site; Apollo and Tata 1mg give Cipla's Mumbai address) |
| Form and device | Dry powder hard capsule for inhalation. The container in our product photo says "For use with rotahaler" |
| Used for | COPD symptoms (PharmEasy, Apollo, Tata 1mg). Apollo also mentions asthma; see below |
| Regulatory status | Not approved by the FDA or Health Canada; we found no licence for it from the MHRA and no TGA registration. No levosalbutamol (levalbuterol) with ipratropium product is approved in the US or Canada, and we found none in the UK or Australia |
| Usual dose | Set by your doctor. The Indian listings give no frequency. The licensed racemic combination inhaler, Combivent Respimat, is one inhalation four times a day, with no more than six in 24 hours (US label 2) |
| Timing | No data for Duolin Rotacaps. Combivent Respimat: median onset 13 minutes; action "should last 4 to 5 hours or longer" (US label 14, 17) |
| Packs | 1, 2 and 3 containers of 30 capsules (30, 60 and 90 capsules) |
| Price per capsule | $0.37 (1 container) down to $0.32 (3 pack), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
Price per capsule
Prices below are as of October 2026; the pack selector shows the current price.
| Pack | Capsules | Price | Per capsule | Shipping | Per capsule with shipping |
|---|---|---|---|---|---|
| 1 container | 30 | $11.13 | $0.37 | $25 | $1.20 |
| 2 containers | 60 | $20 | $0.33 | $25 | $0.75 |
| 3 containers | 90 | $29 | $0.32 | $25 | $0.60 |
All three packs are under the $149 free shipping line, so each single order carries $25 shipping, and on the 1 container pack shipping costs more than the capsules. The larger packs are also cheaper per capsule before shipping. If you also need a Rotahaler, it is a separate item in our shop.
How long a container lasts. This is our arithmetic, not a label figure, because we have no labelled schedule for Duolin Rotacaps. A container of 30 capsules gives 30 doses of one capsule: 15 days at two capsules a day, 10 days at three, or about 7 days at four. So the 3 pack covers about 45 days at two a day, 30 days at three, or about 22 days at four. Ask your doctor how many capsules a day you need before you choose a pack, and check that the expiry date on each container covers the weeks you need.
Regulatory status outside India
Duolin pairs two medicines that are each licensed somewhere, but we found the pair itself licensed in none of the four countries we ship to. On 22 October 2026 we searched the FDA's drug approvals database (openFDA) and Health Canada's Drug Product Database for products containing both ipratropium and levalbuterol and found none. The UK electronic medicines compendium (emc) has no levosalbutamol product at all, and an MHRA products database search for levosalbutamol on 16 October 2026 returned only racemic salbutamol with ipratropium nebuliser solutions. We could not search Australia's register (the ARTG) directly, so treat Australia as "none found". The emc is not the full MHRA register, so treat the UK finding the same way.
- Levosalbutamol (levalbuterol) alone: licensed in the US as Xopenex HFA and generic levalbuterol inhalers and nebuliser solutions. We found no levosalbutamol product in Health Canada's database or on the UK emc.
- Ipratropium alone: licensed everywhere we ship. Atrovent HFA and a generic ipratropium inhaler in the US, Atrovent HFA in Canada, the Atrovent Inhaler and Cipla's own Ipravent inhaler on the UK emc, and the Atrovent metered aerosol in Australia (Schedule 4).
- Racemic salbutamol (albuterol) with ipratropium: Combivent Respimat in the US and Canada, and generic nebuliser solutions in the US and Canada (Health Canada lists Teva-Combo Sterinebs and a Juno ipratropium with salbutamol solution as marketed). In the UK the emc and MHRA listings we found are nebuliser solutions only (Combivent UDVs, Ipramol Steri-Neb and others). Health Canada lists the older Combivent inhalation aerosol as cancelled.
In India, the published list of fixed dose combinations approved by the drug controller (DCG(I)) records a salbutamol with ipratropium inhaler (6 March 2000) and nebuliser solution (3 April 2001). We could not find levosalbutamol with ipratropium in the lists we hold (1961 to 2019, and the later lists we hold, which cover parts of 2020 to March 2025). Levosalbutamol products may have reached the market by another approval route, and we have not seen Cipla's approval document, so we cannot confirm or rule out an approval. In a PubMed search on 22 October 2026 we found no clinical trial of Duolin Rotacaps, or of any levosalbutamol with ipratropium dry powder capsule. The only paper we found on a fixed levosalbutamol with ipratropium product was a laboratory test of the particle size from a levosalbutamol 50 mcg with ipratropium 20 mcg pressurised inhaler; the clinical studies we found that gave levalbuterol with ipratropium used nebulised solutions in acute asthma, not a capsule.
Compared with Combivent Respimat, Atrovent and levalbuterol inhalers
| Product (not the same as Duolin) | What it is | FDA approved | US pharmacy cost (NADAC) | Per inhalation or dose |
|---|---|---|---|---|
| Duolin Rotacaps (ours) | Levosalbutamol 100 mcg with ipratropium 40 mcg per capsule | No | $0.32 to $0.37 per capsule, our price before shipping | $0.32 to $0.37 per capsule; about $1.29 to $1.48 a day at four capsules (our arithmetic) |
| Combivent Respimat | Ipratropium bromide 20 mcg with albuterol 100 mcg per inhalation, 120 inhalations per 4 g cartridge | Yes | $124.15157 per gram (about $497 a cartridge) | About $4.14 per inhalation, or about $16.55 a day at the label's four inhalations |
| Atrovent HFA (brand) | Ipratropium bromide 17 mcg per inhalation from the mouthpiece, 200 inhalations, 12.9 g | Yes | $22.76086 per gram (about $294 an inhaler) | About $1.47 per inhalation |
| Generic ipratropium HFA 17 mcg | Ipratropium bromide inhaler, 200 inhalations | Yes | $21.67441 per gram | Not calculated (we could not confirm the canister weight) |
| Xopenex HFA (brand) | Levalbuterol 45 mcg per inhalation from the mouthpiece, 200 inhalations, 15 g | Yes | $4.98458 per gram (about $74.77 an inhaler) | About $0.37 per inhalation |
| Generic levalbuterol HFA 45 mcg | Levalbuterol inhaler, 200 inhalations, 15 g | Yes | $3.55375 per gram (about $53.31 an inhaler) | About $0.27 per inhalation |
| Generic ipratropium with albuterol nebuliser solution | Ipratropium 0.5 mg with albuterol 2.5 mg in a 3 mL vial, used in a nebuliser | Yes | $0.07646 to $0.08078 per mL | About $0.23 to $0.24 per vial |
NADAC (National Average Drug Acquisition Cost) is what US pharmacies pay to buy a medicine, published by the US Medicaid programme; it is not the price a patient pays at the counter. Every row shown is from the NADAC file dated 21 October 2026, with an effective date of 21 October 2026. Per inhaler, per inhalation and per day figures are our arithmetic from the per gram or per mL rates and the label fill and dose (Combivent Respimat 4 g, Atrovent HFA 12.9 g, Xopenex HFA and the generic levalbuterol inhaler 15 g). There was no NADAC row for a levalbuterol with ipratropium product, because none is sold in the US.
Two things are plain from this table. Our per day cost is far below the US pharmacy cost of Combivent Respimat. But a US generic ipratropium with albuterol nebuliser vial costs US pharmacies less than one of our capsules, though it needs a nebuliser, and a puff from a generic levalbuterol inhaler (about $0.27) costs US pharmacies less than one of our capsules, though it contains no ipratropium. These are different products, approved on their own trials, and Duolin is not a generic of any of them. If you are in the US, the UK, Canada or Australia and have a prescription, ask your doctor or pharmacist about the licensed options and your insurance or subsidised price first.
Duolin forms and related capsules
| Product | Contents | Device | What the labels say about this amount |
|---|---|---|---|
| Duolin Rotacaps (this page) | Levosalbutamol 100 mcg with ipratropium 40 mcg per capsule | Dry powder capsule for a Rotahaler | 40 mcg of ipratropium matches 2 puffs of the UK Atrovent inhaler (20 mcg each, ex-valve; the label's usual dose is 1 or 2 puffs). 100 mcg of levosalbutamol is close to the levalbuterol in 2 Xopenex HFA puffs from the valve (51.6 mcg each). Capsule contents are not the same as the dose that leaves a device (our comparison) |
| Duolin Forte Rotacaps | Levosalbutamol 100 mcg with ipratropium 80 mcg per capsule (PharmEasy listing) | Dry powder capsule | Twice the ipratropium of Duolin Rotacaps per capsule. The UK Atrovent label says some patients may need up to 4 puffs (80 mcg ex-valve, our arithmetic) at a time "during early treatment". A change to Forte is a decision for your doctor |
| Duolin Respules | Levosalbutamol with ipratropium nebuliser solution | Nebuliser | A different form for people who use a nebuliser; see its page |
| Ipravent Rotacaps 40 | Ipratropium 40 mcg per capsule, no levosalbutamol | Dry powder capsule | Ipratropium alone |
| Asthalin Rotacaps | Salbutamol 200 mcg per capsule, no ipratropium | Dry powder capsule | Racemic salbutamol alone, a reliever |
The same number of micrograms in different devices does not mean the same dose reaches the lungs. The US Spiriva HandiHaler label, for another dry powder capsule, says the amount delivered to the lungs varies with how hard the patient breathes in through the device and with how long the capsule has been outside its pack. The Indian listings do not say how much of Duolin's 100 mcg and 40 mcg leaves a Rotahaler. Moving between these products, or from them to a licensed inhaler, is a decision for your doctor.
How often to use it: what the labels say
We have not seen Cipla's prescribing information for Duolin Rotacaps, so we cannot quote its labelled schedule. The PharmEasy listing tells you to take it "exactly as directed by your doctor", Apollo says "Your doctor will recommend how often you use Duolin Rotacaps", and Tata 1mg says your doctor will tell you how often. The labels for the licensed relatives give these schedules:
- Combivent Respimat (US): one inhalation (ipratropium bromide 20 mcg with albuterol 100 mcg) four times a day. "Patients may take additional inhalations as required; however, the total number of inhalations should not exceed six in 24 hours." The label adds that the safety and efficacy of extra doses of ipratropium or albuterol on top of Combivent Respimat have not been studied.
- Atrovent HFA (US): two inhalations four times a day, and no more than 12 inhalations in 24 hours. Atrovent Inhaler (UK): usually 1 or 2 puffs three or four times daily, although some patients may need up to 4 puffs at a time during early treatment; "The recommended dose should not be exceeded."
- Xopenex HFA (US): 2 inhalations (90 mcg of levalbuterol) every 4 to 6 hours; "More frequent administration or a larger number of inhalations is not routinely recommended."
Follow the schedule your doctor sets and do not add extra capsules. If your usual dose stops working as well, or you need it more often than usual, the US Combivent Respimat label says "medical attention should be sought immediately". That is a sign your COPD needs review, not a reason to take more.
How to use the Rotahaler with Duolin capsules
These steps follow Cipla's Rotahaler instructions on CiplaMed. Read the leaflet in your pack and the leaflet with your device first, and follow them where they differ from ours. A Rotahaler works differently from a spray inhaler: there is nothing to shake or press, and the powder only leaves the capsule if you breathe in fast and deep.
- Never swallow a capsule. The Apollo listing says "It is for inhalation only. Do not swallow the capsule", and Tata 1mg says rotacaps must not be swallowed. If you swallow one by mistake, it will not work as intended; ask your doctor or pharmacist before your next dose rather than taking an extra capsule (our advice).
- Hold the Rotahaler upright and line up its two halves so the fin is not directly below the rotacap hole.
- Take one capsule out of its container only when you are ready to use it, and push it into the rotacap hole with the transparent end facing down. Close the container tightly straight away.
- Hold the mouthpiece firmly with one hand and rotate the base. This opens the capsule.
- Breathe out fully, away from the mouthpiece so you do not blow moisture into the device (our addition). Put the mouthpiece between your teeth, close your lips tightly around it, tilt your head slightly back and breathe in through your mouth quickly and deeply.
- Hold your breath for 10 seconds, or as long as is comfortable, then breathe out normally. If some powder remains in the capsule, breathe in from the device again.
- Open the Rotahaler and throw away the empty capsule shell.
- Keep the powder out of your eyes. The US Combivent Respimat and Atrovent HFA labels say ipratropium in the eyes can cause eye pain, blurred vision, enlarged pupils and red eyes, and can bring on or worsen narrow-angle glaucoma.
- Clean the device as Cipla's instructions say: separate the two halves, rinse them in clean running water, shake off the water and leave them to air dry. Never use the Rotahaler while it is wet, do not push a cloth or instrument into the mouthpiece, and replace the device after up to 6 months of daily use.
- Rinsing your mouth with water after each dose and spitting it out can help with dry mouth and throat irritation (Apollo and Tata 1mg listings).
- If you miss a dose, take it when you remember unless the next dose is nearly due, and do not take a double dose (PharmEasy listing).
A Rotahaler needs a fast, deep breath. If you are too breathless to breathe in hard, for example during a flare-up, a capsule may not empty properly; tell your doctor, who may suggest a spray inhaler with a spacer or a nebuliser instead (our advice, based on the Spiriva HandiHaler label's point that delivery to the lungs depends on how hard you breathe in). The container in our product photo says "For use with rotahaler". Cipla also makes the Revolizer, but because the Duolin container names the Rotahaler, ask your pharmacist before using another device.
Keeping the capsules dry
Dry powder capsules are sensitive to moisture: damp powder can clump and stay in the capsule instead of reaching your lungs. Cipla's Rotahaler instructions say "Keep the rotacap bottle tightly closed to avoid exposure to moisture" and to take a rotacap out just before use. The container label in our photo says to keep the container tightly closed and to protect it from heat and moisture; we cannot read its storage temperature in the photo. The Indian listings disagree on temperature: PharmEasy says below 25 C, "protected from moisture, sunlight and heat"; Apollo gives 20 C to 25 C in one place and below 30 C in another; Tata 1mg says below 30 C. None of them says to refrigerate. Follow the carton.
- Close the cap fully after every capsule, and keep the capsules in their own container. Do not move them into a pill organiser or a bag (our advice).
- Do not keep the container in a bathroom, a kitchen near the kettle or stove, or a hot car (our advice).
- Never leave a capsule in the Rotahaler between doses. The US Spiriva HandiHaler label gives the same rule for its own capsules and device, and tells patients to remove one capsule only immediately before use "or its effectiveness may be reduced", and to throw away capsules that have been open to air.
- If capsules look soft, sticky, cracked or discoloured, or the powder has formed lumps, do not use them; ask your pharmacist (our advice).
Your order may spend 7 to 14 business days in transit. When it arrives, check that the container seal is intact before you open it.
Regular treatment, reliever, or both?
Both medicines in Duolin are short-acting, and the labels for the licensed relatives treat them differently. Combivent Respimat is for people with COPD "on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator", used four times a day. Atrovent HFA is for maintenance treatment and "is not indicated for the initial treatment of acute episodes of bronchospasm where rescue therapy is required for rapid response", and the UK Atrovent label says the onset of ipratropium is slower than that of inhaled sympathomimetic bronchodilators. Xopenex HFA, levalbuterol alone, is used to treat or prevent bronchospasm. The Indian listings disagree too: a PharmEasy answer says Duolin "is not used to relieve sudden breathing problems", while an Apollo answer says it "may help relieve acute bronchospasm" as directed by your doctor.
So ask your doctor whether Duolin Rotacaps is your regular treatment, your reliever, or both, and write it into your COPD action plan. Do not use a separate salbutamol or levosalbutamol reliever, such as Asthalin or Levolin inhalers, on top of Duolin unless your doctor has planned it: the US Xopenex HFA label (section 7) says other short-acting sympathomimetic aerosol bronchodilators "should not be used concomitantly" with it.
In COPD, NICE (UK) advises short-acting bronchodilators "as necessary, as the initial empirical treatment", and offering a long-acting antimuscarinic with a long-acting beta2 agonist (LAMA+LABA) to people with spirometry-confirmed COPD and no asthmatic features who stay breathless or have flare-ups despite a short-acting bronchodilator (recommendations 1.2.6 and 1.2.10). If you need Duolin every day and still struggle, ask your doctor whether a long-acting inhaler, such as Duova Rotacaps or Tiova Rotacaps, would suit you better. Do not use a long-acting antimuscarinic such as tiotropium together with Duolin unless your doctor has planned it, because both Duolin and those inhalers contain an antimuscarinic (see interactions below).
Asthma. Apollo also describes Duolin for asthma. Duolin contains no inhaled steroid. The US Xopenex HFA label says "The use of a beta-adrenergic agonist alone may not be adequate to control asthma in many patients" and that early consideration should be given to anti-inflammatory medicines such as corticosteroids. The UK Atrovent label does include chronic asthma, but if you have asthma, use Duolin only as part of a plan from your doctor that includes a steroid inhaler (our view).
Kidney, liver and older age
- Kidney impairment: the US Xopenex HFA label says albuterol "is known to be substantially excreted by the kidney, and the risk of toxic reactions may be greater in patients with impaired renal function", and advises caution with high doses. The Combivent Respimat and Atrovent HFA labels say their pharmacokinetics have not been studied in kidney or liver impairment.
- Liver impairment: no data in the US labels (see above). PharmEasy tells you to talk to your doctor if you have liver or kidney problems.
- Older people: in the Combivent Respimat trial, people aged 65 and over had higher blood levels of both medicines, but the label says no dose adjustment "is warranted". The Xopenex HFA label says dose selection for older people should be cautious, usually starting at the low end of the range. PharmEasy says older people are more likely to get side effects.
Side effects
We found no published side effect table for Duolin Rotacaps, so here are the tables for the closest licensed products. They come from other devices and doses, and from separate trials; do not add them together.
| Reaction | Combivent Respimat 20/100 mcg (486 people) | Older Combivent CFC aerosol (491 people) | Ipratropium Respimat 20 mcg (483 people) |
|---|---|---|---|
| Any adverse reaction | 46% | 52% | 45% |
| Nasopharyngitis | 4% | 3% | 4% |
| Cough | 3% | 2% | 2% |
| Headache | 3% | 2% | 3% |
| Bronchitis | 3% | 3% | 1% |
| Upper respiratory infection | 3% | 4% | 3% |
| Dyspnoea (breathlessness) | 2% | 2% | 3% |
Table 1 of the US Combivent Respimat label: all reactions in 2% or more of the Combivent Respimat group in a 12 week COPD trial, four times a day, with no placebo arm. Reactions under 2% included dizziness, tremor, dry mouth, nausea, constipation, palpitations, fast heartbeat, high blood pressure, low potassium and eye pain. In a 48 week open-label trial, cough was more common with Combivent Respimat (7.0%) than with the older aerosol (2.6%) or separate ipratropium and albuterol inhalers (3.9%).
| Reaction | Atrovent HFA 42 mcg (243 people) | Placebo (128 people) |
|---|---|---|
| Bronchitis | 10% | 6% |
| COPD exacerbation | 8% | 13% |
| Dyspnoea | 8% | 4% |
| Headache | 6% | 8% |
| Dry mouth | 4% | 2% |
| Nausea | 4% | 2% |
| Influenza-like symptoms | 4% | 2% |
| Dizziness | 3% | 2% |
Selected rows from Table 1 of the US Atrovent HFA label (two 12 week COPD studies; placebo in one study only). The label adds that bitter taste and dry mouth were the most common drug-related events, and lists anticholinergic effects such as glaucoma, blurred vision, enlarged pupils, fast heartbeat, palpitations, constipation and urinary retention. The UK Atrovent label lists headache, dizziness, throat irritation, cough, dry mouth, nausea and gut motility disorders as common. For the levosalbutamol part, the US Xopenex HFA label lists palpitations, chest pain, rapid heart rate, tremor and nervousness as common beta-agonist effects, and beta2 agonists can lower blood potassium (warning 5.8: "usually transient").
When to get urgent help
- Breathing that gets worse quickly, or a dose that does not relieve it: call emergency services now (911 in the US and Canada, 999 in the UK, 000 in Australia) or go to the nearest emergency department. The US Combivent Respimat label says medical attention "should be sought immediately" if treatment becomes less effective, symptoms get worse or you need it more often than usual, and the UK Atrovent label says that in acute or rapidly worsening breathlessness a physician "should be consulted immediately".
- Wheezing or breathlessness that gets worse straight after a dose (paradoxical bronchospasm): the US Combivent Respimat label says it "can be life-threatening" and the medicine should be stopped immediately. The UK Atrovent label says it should be treated straight away with a fast-acting inhaled bronchodilator. Use the reliever in your plan, stop Duolin and get medical help now.
- Swelling of the face, lips, tongue or throat, trouble breathing or swallowing, hives, rash or itching: signs of an allergic reaction. The US Combivent Respimat label says to stop it immediately and consult a physician; get emergency help if breathing or swallowing is affected (our advice).
- Eye pain or discomfort, blurred vision, halos or coloured images around lights, with red eyes: possible acute narrow-angle glaucoma. The US labels say to consult a physician immediately; the UK Atrovent label says specialist advice should be sought immediately. In our view this needs emergency eye care the same day.
- Difficulty passing urine: the US labels say to consult your physician. Being unable to pass urine at all needs emergency care (our advice).
- Chest pain, a very fast or irregular heartbeat, fainting or a seizure. The US Combivent Respimat label mentions rare reports of reduced blood flow to the heart muscle (myocardial ischaemia) with albuterol.
- Taking far more capsules than prescribed. The US Combivent Respimat label says overdose effects come mainly from the albuterol part and may include anginal (chest) pain, high blood pressure, low potassium and a heart rate up to 200 beats a minute, and that cardiac arrest and even death may be associated with abuse of beta2 agonist inhalers. For poisoning advice, call 1-800-222-1222 in the US or 13 11 26 in Australia.
Tell the emergency staff which inhalers you use, how many capsules you took and when.
Who should not use Duolin Rotacaps
Never use it (contraindications in the single-ingredient and combination labels):
- if you are allergic to ipratropium or to atropine or any of its derivatives (US Combivent Respimat and Atrovent HFA labels, UK Atrovent label 4.3)
- if you are allergic to levalbuterol or racemic albuterol (salbutamol) (US Xopenex HFA label)
- if you are allergic to any other ingredient of the capsule
The PharmEasy listing also lists heart problems and age under 12 under its contraindications. Those are listing statements, not label contraindications we have seen; the US labels treat heart disease as a caution (below).
Use with caution, and talk to a doctor first:
- Narrow-angle glaucoma, an enlarged prostate or bladder-neck obstruction (US Combivent Respimat 5.3 and 5.4; UK Atrovent 4.4). The Combivent trial excluded people with these conditions.
- Heart disease, especially coronary insufficiency, irregular heart rhythm and high blood pressure (US Combivent Respimat 5.2). Beta agonists can cause ECG changes, including a longer QTc interval.
- Seizure disorders, an overactive thyroid, diabetes, or being unusually sensitive to sympathomimetic medicines (US Combivent Respimat 5.7). PharmEasy also tells you to talk to your doctor if you have diabetes.
- Cystic fibrosis: the UK Atrovent label advises caution because of a tendency to gut motility problems.
- Milk protein allergy. Many dry powder capsules use lactose as a carrier, and the US Spiriva HandiHaler label says its lactose may contain milk proteins. The Duolin listings we checked do not name the excipients and we cannot read that line on the container in our photo, so ask the pharmacist to check the leaflet (our advice).
- Medicines:
- other anticholinergic inhalers or medicines, such as tiotropium, glycopyrronium or another ipratropium product: the US Combivent Respimat and Atrovent HFA labels say avoid using them together, and the UK Atrovent label says chronic co-administration "is not recommended";
- other short-acting beta agonist inhalers such as salbutamol or levosalbutamol, and epinephrine: the US Xopenex HFA label says they "should not be used concomitantly"; the Combivent Respimat label advises caution with other sympathomimetic agents;
- beta blockers: they and albuterol block each other's effect, and the Combivent Respimat label advises caution in people with hyperreactive airways; the Xopenex HFA label says people with asthma "should not normally be treated with beta-blockers";
- water tablets (loop or thiazide diuretics), which can add to low potassium: consider monitoring potassium (Combivent Respimat 7.4);
- MAO inhibitors or tricyclic antidepressants, now or in the last 2 weeks: "extreme caution", and consider alternative therapy (Combivent Respimat 7.5);
- digoxin: the Xopenex HFA label says it would be prudent to check digoxin levels.
- Pregnancy: the US Combivent Respimat label says there are no randomised studies in pregnant women, and decades of published data have not identified a drug-associated risk of major birth defects with ipratropium; because beta agonists may interfere with contractions, use during labour should be restricted to people "in whom the benefits clearly outweigh the risk". The UK Atrovent label says it "should not be used in pregnancy or lactation unless the expected benefits to the mother are thought to outweigh any potential risks to the fetus or neonate".
- Breastfeeding: the US Combivent Respimat label says there are no data on either medicine in human milk and levels are likely to be low. The UK Atrovent label says caution should be exercised in nursing mothers. The PharmEasy listing goes further and says you should not breastfeed while taking it; ask your doctor.
- Children: the US Combivent Respimat label says safety and effectiveness in children have not been established and that COPD "does not normally occur in children". PharmEasy says it is not recommended under 12. Duolin Rotacaps are not a children's medicine.
- Driving: dizziness, blurred vision and enlarged pupils can occur, so the US Combivent Respimat label advises care with driving or machinery.
Prescription and legal status
Ipratropium inhalers are prescription-only in the US, the UK (the Atrovent Inhaler is a prescription only medicine on the emc), Canada (Health Canada lists Combivent Respimat and Atrovent HFA as prescription) and Australia (the Atrovent metered aerosol is Schedule 4). Levalbuterol inhalers are prescription-only in the US, the only one of these countries where we found one licensed (the FDA lists Combivent Respimat, Atrovent HFA and Xopenex HFA as prescription products). In India, the container in our product photo is marked "Rx", Apollo marks Duolin Rotacaps as a prescription drug and Tata 1mg says a prescription is required. Duolin Rotacaps are not approved in the US or Canada, and we found no licence in the UK or Australia. In the US the FDA says personal importation of unapproved medicines is illegal in most circumstances. COPD needs regular review by a doctor or nurse, including spirometry, an inhaler technique check and a plan for flare-ups. Check the rules where you live.
Buying genuine Duolin Rotacaps
The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It also advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo." That warning covers Duolin Rotacaps, which are not authorised in the UK. When your order arrives, check that the carton and container name Cipla, levosalbutamol and ipratropium, say 30 capsules, are sealed, and show a batch number and an expiry date. These checks cannot prove a pack is genuine, because counterfeiters copy packaging. If the capsules do not seem to work the way your previous supply did, see a doctor rather than taking extra capsules. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.
Delivery
We ship Duolin Rotacaps to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries, so order well before your current container runs out, and keep a supply plan agreed with your doctor in case of delays. Shipping costs a flat $25 on orders under $149 and is free from $149. See our shipping page and refund policy.
Related guides
- Rotacaps vs inhaler vs respules: which device gets the dose into your lungs
- Salbutamol vs levosalbutamol: what the enantiomer evidence shows
- Tiotropium inhaler guide: why 18 mcg and 5 mcg are the same dose, and who benefits
- Breztri vs Trelegy: triple inhalers for COPD and asthma compared
Other products mentioned on this page: Levolin 0.63mg Respules (levosalbutamol nebuliser solution), Duova Rotacaps (tiotropium with formoterol) and the Rotahaler device.
Sources
- Combivent Respimat (ipratropium bromide and albuterol inhalation spray), Boehringer Ingelheim, US prescribing information and Instructions for Use, DailyMed setid 9832312e-0310-4ab6-8501-afa976fc7eb2, version 18, December 2025, sections 1 to 8, 10, 11, 12.3, 14, 16 and 17. DailyMed
- Atrovent HFA (ipratropium bromide HFA inhalation aerosol), Boehringer Ingelheim, US prescribing information and Instructions for Use, DailyMed setid 170e98ef-5560-4068-be7d-e649068eb884, version 21, November 2025, sections 1 to 8, 10, 11, 12.3, 14, 16 and 17. DailyMed
- Xopenex HFA (levalbuterol tartrate inhalation aerosol), Lupin, US prescribing information and patient information, DailyMed setid 70a35706-d7a8-4a48-98c6-1cab1c42fe8d, version 3, July 2025, sections 1 to 8, 10, 11, 12.2, 14, 16 and 17. DailyMed
- Levalbuterol tartrate HFA inhalation aerosol, Actavis, US prescribing information, DailyMed setid ac85703a-17a2-4f0b-87f4-78f1756d2f85, version 20, October 2023, section 16 (15 g canister, 200 actuations). DailyMed
- Atrovent Inhaler CFC-Free 20 micrograms/actuation. UK summary of product characteristics, Boehringer Ingelheim, PL 00015/0266, revised 22 March 2021, sections 4.1 to 4.9 and 6.4. emc
- Spiriva HandiHaler (tiotropium bromide inhalation powder), US prescribing information, DailyMed setid 820839ef-e53d-47e8-a3b9-d911ff92e6a9, version 28, November 2025, sections 11, 16 and 17 (capsule handling, moisture and device delivery). DailyMed
- NICE guideline NG115. Chronic obstructive pulmonary disease in over 16s: diagnosis and management, recommendations 1.2.6 and 1.2.10. NICE
- Central Drugs Standard Control Organisation. Fixed dose combinations approved by DCG(I) since 1961 to 31st December 2019, items 291 (salbutamol with ipratropium inhaler, 06.03.2000) and 301 (ipratropium with salbutamol respirator solution, 03.04.2001), and later lists covering parts of 2020 to March 2025. CDSCO
- US FDA drug approvals (openFDA drugsfda) and Health Canada Drug Product Database, searched for ipratropium and levalbuterol on 22 October 2026; UK emc searched for ipratropium and levosalbutamol on 22 October 2026; MHRA products database searched for levosalbutamol on 16 October 2026. openFDA, Health Canada DPD
- healthdirect Australia. Atrovent, Schedule 4 prescription only medicine. healthdirect
- Cipla (CiplaMed). How to use the Rotahaler, patient education page, 14 October 2016. CiplaMed
- Chilka, et al. Evaluation of respirable fraction by using Next Generation Impactor of levosalbutamol sulphate and ipratropium bromide metered dose inhaler. Curr Drug Res Rev 2026. PMID 40108911.
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), 2026 file dated 21 October 2026: Combivent Respimat, Atrovent HFA, ipratropium HFA, Xopenex HFA, levalbuterol HFA and ipratropium with albuterol nebuliser solution rows. data.medicaid.gov
- PharmEasy, Apollo Pharmacy and Tata 1mg. Duolin Rotacaps and Duolin Forte Rotacaps (Cipla) product listings, accessed 22 October 2026. PharmEasy, Apollo (and its mirror page), Tata 1mg
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Levosalbutamol and ipratropium are prescription medicines; your doctor should set your dose and your COPD action plan.
Frequently asked questions
What is Duolin Rotacaps?
Duolin Rotacaps are Cipla's dry powder capsules for use with a Rotahaler device. Each capsule contains levosalbutamol 100 mcg, a short-acting beta2 agonist bronchodilator, and ipratropium 40 mcg, a short-acting antimuscarinic bronchodilator. Indian pharmacy listings describe them for COPD. No levosalbutamol with ipratropium product is approved by the FDA or Health Canada, and we found none licensed in the UK or registered in Australia.
Is Duolin Rotacaps the same as Combivent Respimat?
No. Combivent Respimat, licensed in the US and Canada, is a spray inhaler with ipratropium bromide 20 mcg and racemic albuterol (salbutamol) 100 mcg per inhalation. Duolin Rotacaps use levosalbutamol, the R-isomer of salbutamol, in a dry powder capsule, and the capsule contents are not a delivered dose. We found no published trial comparing Duolin Rotacaps with Combivent Respimat, and no clinical trial of Duolin Rotacaps at all in a PubMed search on 22 October 2026.
What does Duolin Rotacaps cost?
As of October 2026 it costs $11.13 for 1 container of 30 capsules ($0.37 a capsule), $20 for 2 containers ($0.33) and $29 for 3 containers ($0.32), before shipping. All packs are under $149, so each order carries $25 shipping: $1.20, $0.75 or $0.60 a capsule with shipping. The pack selector shows the current price. By our arithmetic a container lasts 15 days at two capsules a day, 10 days at three, or about 7 days at four.
How do I use Duolin Rotacaps?
Following Cipla's Rotahaler instructions: hold the Rotahaler upright, push one capsule into the rotacap hole with the transparent end down, rotate the base, breathe out away from the device, then close your lips around the mouthpiece and breathe in quickly and deeply. Hold your breath for about 10 seconds, breathe in again if powder remains, and throw away the empty shell. Never swallow a capsule, and keep the powder out of your eyes.
How often should I use Duolin Rotacaps?
As often as your doctor tells you. We have not seen Cipla's prescribing information, and the Indian listings give no frequency. For comparison, the US label for the licensed racemic combination, Combivent Respimat, gives one inhalation four times a day and no more than six in 24 hours. Do not add extra capsules; if your usual dose stops working as well, or you need it more often, the Combivent Respimat label says medical attention should be sought immediately.
What is the difference between Duolin Rotacaps and Duolin Forte?
Duolin Forte Rotacaps contain the same levosalbutamol 100 mcg but twice the ipratropium, 80 mcg per capsule, according to the PharmEasy listing. Duolin Rotacaps contain 40 mcg, the same as 2 puffs of the UK Atrovent inhaler (20 mcg each, ex-valve; the label's usual dose is 1 or 2 puffs). That is the amount in the capsule, not the dose that reaches your lungs. Whether you need the Forte strength is a decision for your doctor, not one to make yourself.
How should I store Duolin Rotacaps?
Keep the container tightly closed and take out one capsule only just before use; Cipla's Rotahaler instructions say this avoids exposure to moisture. PharmEasy says store below 25 C, protected from moisture, sunlight and heat; Tata 1mg says below 30 C. No listing says to refrigerate. Do not keep capsules in the Rotahaler, a pill organiser or a damp bathroom, and do not use capsules that look soft, sticky or discoloured (our advice).
Is Duolin Rotacaps a reliever or a regular treatment?
The labels for its licensed relatives differ. Combivent Respimat is used four times a day by people with COPD who need a second bronchodilator; Atrovent HFA (ipratropium alone) is not for the initial treatment of acute bronchospasm; levalbuterol alone is used to treat or prevent bronchospasm. Ask your doctor which role Duolin has in your COPD plan, and do not use a separate salbutamol or levosalbutamol reliever on top unless your doctor has planned it. Duolin contains no steroid, so it is not an asthma treatment on its own.
What are the side effects of Duolin Rotacaps?
There is no published side effect table for Duolin Rotacaps. In the US Combivent Respimat 12 week COPD trial, nasopharyngitis (4%), cough, headache, bronchitis and upper respiratory infection (3% each) and breathlessness (2%) were the most common. The ipratropium labels add dry mouth, bitter taste, dizziness and nausea; the levalbuterol label adds palpitations, fast heartbeat, tremor and nervousness. Get help at once for breathing that worsens straight after a dose, allergy signs, eye pain with blurred vision, or chest pain.
Who should not use Duolin Rotacaps?
Do not use it if you are allergic to ipratropium, atropine or its derivatives (US and UK ipratropium labels), to levalbuterol or racemic albuterol (US Xopenex HFA label), or to any ingredient. Talk to a doctor first if you have narrow-angle glaucoma, an enlarged prostate or trouble passing urine, heart disease, an overactive thyroid, diabetes or seizures, or if you use other anticholinergic inhalers such as tiotropium, other short-acting beta agonist inhalers, beta blockers, diuretics, MAO inhibitors or tricyclic antidepressants. It is not a children's medicine.
Do I need a prescription, and how long does delivery take?
Ipratropium inhalers are prescription-only in the US, the UK, Canada and Australia, levalbuterol inhalers are prescription-only in the US, and the Duolin container in our photo is marked Rx. Duolin Rotacaps are not approved in the US or Canada, and we found no licence in the UK or Australia; the FDA says personal importation of unapproved medicines is illegal in most circumstances. We ship to the US, UK, Australia and Canada in 7 to 14 business days, with $25 shipping under $149 and free shipping from $149.
Medical References
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Duolin Rotacaps? Tell other buyers how it went.







